Profile
Full Name
Akero Therapeutics, Inc.Ticker Symbol
AKROExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 20, 2019Indexes
Not includedWebsite
http://akerotx.comEmployees
63Key Details
Price
$35.66(+2.43%)
Market cap
$2.84B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.75(-29.76% YoY)
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Akero Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 3, 25 HC Wainwright & Co.
BuyJan 31, 25 UBS
BuyJan 30, 25 B of A Securities
BuyJan 27, 25 HC Wainwright & Co.
BuyJan 16, 25 HC Wainwright & Co.
BuyNov 18, 24 HC Wainwright & Co.
BuyNov 18, 24 Citigroup
BuyNov 11, 24 HC Wainwright & Co.
BuyAug 12, 24 HC Wainwright & Co.
BuyJun 20, 24 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for Akero Therapeutics?
- Does Akero Therapeutics pay dividends?
- What sector is Akero Therapeutics in?
- What industry is Akero Therapeutics in?
- What country is Akero Therapeutics based in?
- When did Akero Therapeutics go public?
- Is Akero Therapeutics in the S&P 500?
- Is Akero Therapeutics in the NASDAQ 100?
- Is Akero Therapeutics in the Dow Jones?
- When was Akero Therapeutics's last earnings report?
- When does Akero Therapeutics report earnings?
- Should I buy Akero Therapeutics stock now?
What is the ticker symbol for Akero Therapeutics?
The ticker symbol for Akero Therapeutics is NASDAQ:AKRO
Does Akero Therapeutics pay dividends?
No, Akero Therapeutics does not pay dividends
What sector is Akero Therapeutics in?
Akero Therapeutics is in the Healthcare sector
What industry is Akero Therapeutics in?
Akero Therapeutics is in the Biotechnology industry
What country is Akero Therapeutics based in?
Akero Therapeutics is headquartered in United States
When did Akero Therapeutics go public?
Akero Therapeutics's initial public offering (IPO) was on June 20, 2019
Is Akero Therapeutics in the S&P 500?
No, Akero Therapeutics is not included in the S&P 500 index
Is Akero Therapeutics in the NASDAQ 100?
No, Akero Therapeutics is not included in the NASDAQ 100 index
Is Akero Therapeutics in the Dow Jones?
No, Akero Therapeutics is not included in the Dow Jones index
When was Akero Therapeutics's last earnings report?
Akero Therapeutics's most recent earnings report was on Feb 28, 2025
When does Akero Therapeutics report earnings?
The next expected earnings date for Akero Therapeutics is May 9, 2025
Should I buy Akero Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions